首页|红芪蜜炙前后配伍醋莪术抗结肠炎相关结直肠癌的药效比较研究

红芪蜜炙前后配伍醋莪术抗结肠炎相关结直肠癌的药效比较研究

扫码查看
目的:基于转录组学结合免疫浸润分析探讨红芪蜜炙前后配伍醋莪术抗结肠炎相关结直肠癌(CAC)的药效及潜在机制差异.方法:75只SPF级C57/6J小鼠随机分为5组:空白组、氧化偶氮甲烷(AOM)/葡聚糖硫酸钠(DSS)组、柳氮磺胺吡啶阳性对照组、红芪∶醋莪术(4∶1)组(6.825 g/kg)及炙红芪∶醋莪术(4∶1)组(6.825 g/kg).采用AOM与DSS联合诱导CAC小鼠模型的同时,各给药组给药干预,空白组给予0.9%氯化钠溶液,干预17周后实验结束.计算各组小鼠体质量、DAI评分、结肠长度、肿瘤计数、生存指数、结肠长度/结肠质量、结肠及脾、胸腺、肝、肺、肾与心等脏器指数,HE染色观察小鼠结肠病变情况,ELISA法检测小鼠血清白介素(IL)-1β及肿瘤坏死因子(TNF)-α表达水平,有参转录组测序结合免疫浸润分析筛选并预测给药后免疫细胞表达情况,流式细胞术对所筛选的免疫细胞进行检测.结果:与AOM/DSS组比较,炙红芪-醋莪术与红芪-醋莪术均可显著升高CAC小鼠体质量、结肠长度、生存率及胸腺指数(P<0.05,P<0.01),显著降低DAI评分、肿瘤计数、HE病理评分、结肠长度/结肠质量及结肠、脾、胸腺、肝、肺等脏器指数与血清IL-1β与TNF-α表达水平(P<0.05,P<0.01);但从结肠HE病理切片评分及TNF-α水平来看,炙红芪-醋莪术的作用要显著优于红芪-醋莪术(P<0.05,P<0.01).有参转录组测序结合免疫浸润分析发现,红芪-醋莪术与炙红芪-醋莪术均可通过上调小鼠脾脏CD4+T淋巴细胞、CD8+T淋巴细胞及CD19+B淋巴细胞表达量,降低CD4+T/CD8+T值;但对小鼠脾脏CD8+T淋巴细胞表达的影响,炙红芪-醋莪术作用显著优于红芪-醋莪术(P<0.01).结论:红芪-醋莪术与炙红芪-醋莪术均具防治CAC作用,机制与调节机体T、B淋巴细胞表达量,改善机体免疫,从而改善炎症状态,延缓炎症进程,改善结肠病变有关.但炙红芪-醋莪术防治CAC优于红芪-醋莪术的机制主要与降低小鼠脾脏CD8+T淋巴细胞与血清TNF-α水平,从而改善小鼠结肠炎病理损伤有关.
Comparative study on efficacy for Hedysari Radix before and after honey-processing paired with vinegar-processed Curcumae Rhizoma against colitis-associated colorectal cancer
Objective:To study on efficacy and immunomodulatory mechanism for Hedysari Radix(HR)before and after honey-processing(HPHR)paired with vinegar-processed Curcumae Rhizoma(VPCR)against colitis-associated colorectal cancer(CAC).Methods:Seventy-five SPF-grade C57/6J mice were randomly divided into five groups:control group,Azoxymethane(AOM)/Dextran sulphate sodium salt(DSS)group,Sulfasalazine group,HR∶VPCR(4∶1)group(6.825 g/kg),and HPHR∶VPCR(4∶1)group(6.825 g/kg).While the CAC mouse model was induced by the combination of AOM and DSS.Each dosing group was given drug intervention and the control group was given saline,and the experiment was ended after 17 weeks of intervention.Body mass,DAI score,colon length,tumor counts,survival index,colon length/colon mass,colon and organ indices such as spleen,thymus,liver,lungs,kidneys and heart were calculated,and colonic lesions were observed by HE staining.The expression levels of interleukin(IL)-1 β and tumor necrosis factor(TNF)-α in serum were detected by ELISA.The expression of the immune cells was screened and predicted by reference transcriptome sequencing combined with immune infiltration analysis.The screened immune cells were detected by flow cytometry.Results:Compared with AOM/DSS group,both HR-VPCR and HPHR-VPCR significantly increased the body mass,colon length,survival rate and thymus index(P<0.05,P<0.01),and significantly decreased the DAI scores,tumor counts,HE pathology scores,colon length/colon mass,and indexes of organs such as the colon,spleen,thymus,liver,and lungs in association with the serum IL-1 β and TNF-α expression levels(P<0.05,P<0.01).However,the effect of HPHR-VPCR was significantly superior to HR-VPCR in terms of HE pathological scores in colon and TNF-α levels in serum(P<0.05,P<0.01).The transcriptome sequencing combined with immune infiltration analysis revealed that both HR-VPCR and HPHR-VPCR could reduce the CD4+T/CD8+T values and up-regulated the expression of CD4+T cells,CD8+T cells,and CD19+B cells in spleen.However,for the effect on the expression of CD8+T cells in spleen,the effect of HPHR-VPCR was significantly better than that of HR-VPCR(P<0.01).Conclusion:Both HR-VPCR and HPHR-VPCR have the effect of treating CAC,and the mechanism is related to regulating the expression of T and B lymphocytes,regulating the immunity of the body,thus improving the inflammation,blocking the process of inflammation,and improving the colonic lesions.However,the mechanism by which HPHR-VPCR was superior to that of HPHR-VPCR in treating CAC was mainly related to lowering the levels of CD8+T cells and TNF-a,which in turn improved the pathological damage of inflammation in the colon.

Hedysari Radix-vinegar-processed Curcumae RhizomaHoney-processed Hedysari Radix-vinegar-processed Curcumae RhizomaColitis-associated colorectal cancer(CAC)EfficacyTranscriptomicsImmune infiltrationImmunomodulation

张育贵、张转红、王彦钧、刘婷、高飞云、李越峰

展开 >

甘肃中医药大学药学院,兰州 730000

甘肃中医药大学科研实验中心,兰州 730000

红芪-醋莪术 炙红芪-醋莪术 结肠炎相关结肠癌 药效 转录组学 免疫浸润 免疫调节

国家自然科学基金国家自然科学基金甘肃省教育厅产业支撑计划甘肃省科技厅科技计划(创新基地与人才计划)基础研究创新群体项目甘肃省教育厅双一流重大科研项目甘肃省中药炮制技术传承基地项目省级人才项目(2024)

81960713821607502021CYZC-2121JR7RA569GSSYLXM-05甘卫中医函[2022]288号甘组通字[2024]4号

2024

中华中医药杂志
中华中医药学会

中华中医药杂志

CSTPCD北大核心
影响因子:1.135
ISSN:1673-1727
年,卷(期):2024.39(5)